Cure My Disease

Don't miss your cure!

 Log in / Sign up

A Pocket-Sized lifeline: can an app ease suicide risk after hospital care?

NCT ID NCT05867316

Disease control Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This study tests whether a mobile app can help adults who are hospitalized for suicide risk use therapy skills during a crisis. The app supplements brief psychotherapy based on the Unified Protocol, which teaches emotion regulation. Participants use the app after discharge, when suicide risk is highest and many skip follow-up therapy. The goal is to see if the app reduces suicidal thoughts and improves confidence in managing negative emotions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A mobile app supplementing brief Unified Protocol-based psychotherapy
What this could lead to
If effective, this approach could provide an accessible, on-demand tool to help people at high risk for suicide manage distressing emotions and reduce suicidal thoughts after hospital discharge.
What could go wrong
This is a small, early-stage trial (66 participants) testing a new intervention, so results may not generalize. The app is an addition to therapy, not a standalone cure, and its success depends on user engagement and real-world usability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Sep 2023

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult status (18+ years) * Admission to eligible units in our partner hospital with a reason for admission having to do with suicide risk * The ability to speak and write English fluently, * Ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone) Exclusion Criteria \- The presence of any factor that impairs an individual's ability to provide informed consent and comprehend and effectively participate in the study including: an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emotion regulation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emotional Regulation Self-Injurious Behavior Suicidal Ideation Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emotion regulation Suicide and self-harm

Contacts and locations

Locations

  • Rutgers University Behavioral Healthcare

    Piscataway, New Jersey, 08854, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.